Peregrine Asset Advisers Inc. Acquires Shares of 2,430 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Peregrine Asset Advisers Inc. bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,430 shares of the exchange traded fund’s stock, valued at approximately $217,000. Several other institutional […]

Related Keywords

United States ,American , ,Securities Exchange Commission ,Axxcess Wealth Management ,York Stock Exchange ,Peregrine Asset Advisers Inc ,National Association Of Securities Dealers Automated Quotation ,New York Stock Exchange ,Nasdaq ,Apollon Wealth Management ,National Market ,Advisor Group ,American Stock Exchange ,Meadowbrook Investment Advisors ,Peregrine Asset Advisers ,Free Report ,Wealth Management ,Brook Investment Advisors ,Trail Advisors ,National Association ,Securities Dealers Automated Quotation ,Visit Holdingschannel ,Spdr Sp Biotech Etf ,Nysearca Xbi ,Xbi ,Nysearca ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,